Capital Fund Management S.A. Novartis Ag Call Options Transaction History

Capital Fund Management S.A.

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $342,509 - $397,269	-3,700 Reduced 24.03%	11,700 $1.25 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $66,689 - $75,929	700 Added 4.76%	15,400 $1.49 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $1.36 Million - $1.49 Million	14,700 New	14,700 $1.48 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $1.07 Million - $1.18 Million	-13,000 Reduced 54.85%	10,700 $930,000
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $1.48 Million - $2.08 Million	21,000 Added 777.78%	23,700 $1.95 Million
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $362,705 - $410,091	-4,300 Reduced 61.43%	2,700 $256,000
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $34,216 - $37,704	-400 Reduced 5.41%	7,000 $608,000
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $6.6 Million - $8.12 Million	-87,500 Reduced 92.2%	7,400 $676,000
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $6.67 Million - $7.42 Million	90,500 Added 2056.82%	94,900 $8.14 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $326,216 - $339,988	4,400	4,400 $378,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.